Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. organic-beauty-recipes.com
WARNING LETTER
•organic-beauty-recipes.com•June 3, 2020

FDA WARNING_LETTER - organic-beauty-recipes.com - June 03, 2020

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

On June 8, 2020, the FDA and FTC issued a Warning Letter to www.organic-beauty-recipes.com for promoting unapproved and misbranded products related to COVID-19. The website, an Amazon Associate, earned commissions by promoting essential oil products with claims implying they could mitigate, prevent, treat, diagnose, or cure COVID-19.

These claims caused the product to be an unapproved new drug under FD&C Act section 505(a) and a misbranded drug under section 502. Prohibited acts include introducing or delivering this product into interstate commerce (sections 301(a) and (d)) and misbranding a drug held for sale after interstate shipment (section 301(k)).

The FDA requested immediate cessation of promoting and participating in the sale of such unapproved products. The company must email COVID-19-Task-Force-CDER@fda.hhs.gov within 48 hours, detailing corrective actions, steps to prevent recurrence, and supporting documentation. Failure to comply may result in legal action, including seizure and injunction, and the firm will be added to FDA’s public list of non-compliant companies.

The FTC also stated that advertising products to prevent, treat, or cure human disease requires competent and reliable scientific evidence, which is lacking for the identified product regarding COVID-19. Violations of the FTC Act may lead to legal

Company
organic-beauty-recipes.com
Inspection Date
June 3, 2020
Product Type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Donald D. Ashley (Director)
  • Richard A. Quaresima
Open in Dashboard

ID · 54d7bc5f-ce99-4fa4-9625-97ed2f65fbc6

Violation Codes5
21.U.S.C. 355(a)21 U.S.C. 35221 U.S.C. 331(d)21 U.S.C. 331(k)21 U.S.C. 331(a)

Full citation text and observation details available on the Dashboard.

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026, Global Key Solutions All rights reserved.